- Posted
- Categories
-
- OpenPrescribing Hospitals
You asked: Can we monitor the usage of biosimilars in secondary care using OpenPrescribing Hospitals?
What are biosimilars, why are they of interest and why can we monitor usage with primary care data but not secondary care data?